在帕金森病模型中,化α-synuclein驱动线粒体功能障碍和调节障碍
Jie Jiao1, Weijin Liu1,2, Ge Gao1
1Department of Neurobiology, Beijing Key Laboratory of Neural Regeneration and Repair, Beijing Key Laboratory on Parkinson's Disease, Key Laboratory for Neurodegenerative Disease of the Ministry of Education, School of Basic Medical Sciences, Beijing Institute of Brain Disorders, Collaborative Innovation Center for Brain Disorders, Capital Medical University, Beijing, China.
酸化α-synuclein (p-α-syn) 通过破坏线粒体信号传递来驱动帕金森病. 抑制这种酸化可以挽救线粒体的功能,揭示了PD的新治疗点.
科学领域:
- 神经科学是一个神经科学.
- 细胞生物学 细胞生物学
- 生物化学 生物化学
背景情况:
- 在血清-129 (p-α-syn) 的α-synuclein的酸化是帕金森病 (PD) 的关键病理标志物.
- 通过p-α-syn促进神经毒性的精确机制,特别是线粒体功能障碍,尚未完全理解.
研究的目的:
- 阐明了帕金森病中p-α-syn诱导的线粒体功能障碍背后的分子标和机制.
- 为了研究p-α-syn在平衡破坏中的作用.
主要方法:
- 从过度表达人类α-synuclein (h-α-syn) 的小鼠中利用了原发皮质神经元.
- 使用共免疫沉 (CO-IP) 与质谱学 (MS) 结合,以确定p-α-syn结合伙伴.
- 评估线粒体功能和信号传递.
主要成果:
- 增加的p-α-syn水平与线粒体功能障碍相关.
- 抑制Ser129酸化改善了线粒体功能.
- 确定了PTPIP51和VAPB,它们是线粒体关联ER膜 (MAM) 的蛋白质,作为p-α-syn结合伙伴.
- 通过p-α-syn与PTPIP51/VAPB结合,破坏了ER-线粒体的转移,并抑制了酸化,部分恢复了平衡.
结论:
- 通过与MAM蛋白PTPIP51和VAPB相互作用,p-α-syn破坏了线粒体功能和平衡.
- 这种相互作用代表了一种新的机制,有助于帕金森病的发病.
- 向Ser129酸化为PD提供了一个潜在的治疗策略.
更多相关视频
06:50Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions
Published on: January 26, 2024
10:03Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons
Published on: August 16, 2020
相关概念视频
Phosphorylation
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Amplifying Signals via Enzymatic Cascade
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
GPCR Desensitization
